Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Semra Aydin"'
Autor:
Semra Aydin, Jennifer Schmitz, Chiara Maria Dellacasa, Irene Dogliotti, Luisa Giaccone, Alessandro Busca
Publikováno v:
HemaSphere, Vol 7, p e87899bd (2023)
Externí odkaz:
https://doaj.org/article/c224b061a5074f2e9d80313a88d735ce
Autor:
Irene Urbino, Chiara Frairia, Alessandro Busca, Silvia Corcione, Stefano D'Ardia, Chiara Maria Dellacasa, Valentina Giai, Carolina Secreto, Roberto Freilone, Francesco Giuseppe De Rosa, Semra Aydin, Giovannino Ciccone, Rosalba Rosato, Marco Cerrano, Ernesta Audisio
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 15, Iss 1 (2023)
Background and objectives: acute myeloid leukemia (AML) patients are at high risk of infections during post induction neutropenia. Recently, the role of antibacterial prophylaxis has been reconsidered due to concerns about the emergence of multi-resi
Externí odkaz:
https://doaj.org/article/d0581b4b379640d0a9a8451bf09c3429
Publikováno v:
IEEE Access, Vol 10, Pp 74961-74976 (2022)
The final stage of the production process in the industry is quality control. Quality control answers the question of is there a defect on the surface of the products. Frequently the quality control is performed manually. The disadvantages of manual
Externí odkaz:
https://doaj.org/article/4106fb73657c41a8b76627588551053e
Autor:
Yuliya Yakymiv, Stefania Augeri, Cristiano Bracci, Sara Marchisio, Semra Aydin, Stefano D’Ardia, Massimo Massaia, Enza Ferrero, Erika Ortolan, Ada Funaro
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
Abstract CD157/BST-1 (a member of the ADP-ribosyl cyclase family) is expressed at variable levels in 97% of patients with acute myeloid leukemia (AML), and is currently under investigation as a target for antibody-based immunotherapy. We used periphe
Externí odkaz:
https://doaj.org/article/e9e93bf36a764005b7551cdd3f88294d
Autor:
Semra AYDIN
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss , Pp S7- (2022)
Clinical signs arising from intravascular hemolysis, hemolysis-related transfusions and thrombosis are indications for treatment initiation in paroxysmal nocturnal hemoglobinuria (PNH), whereas clone size per se is not. Eculizumab prevents intravascu
Externí odkaz:
https://doaj.org/article/7005fa73e5f1470bbbd7dfd52550bb8d
Autor:
Semra Aydin, Valentina Giai, Stefano D'ardia, Giorgia Iovino, Chiara Frairia, Irene Urbino, Marco Cerrano, Eloise Beggiato, Ernesta Audisio
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss , Pp S37- (2022)
Objective: Paroxysmal nocturnal hemoglobinuria (PNH) has always been considered a relative contraindication for pregnancy. The use of eculizumab has reduced morbidity and mortality of fetus and mother. Dose adjustments are often required due to emerg
Externí odkaz:
https://doaj.org/article/836e78707b4b4ccb8d35de130b1b764a
Autor:
Semra Aydin, Chiara Dellacasa, Sara Manetta, Luisa Giaccone, Laura Godio, Giorgia Iovino, Benedetto Bruno, Alessandro Busca
Publikováno v:
Therapeutic Advances in Hematology, Vol 11 (2020)
Background: Patients with post-transplant cytopenias due to poor graft function or primary engraftment failure show poor prognosis with a high mortality rate mainly because of graft versus host disease (GVHD), infection and/or bleeding. Treatment opt
Externí odkaz:
https://doaj.org/article/591132220bad454a83cd9b71bca99cc5
Autor:
Alessia Castellino, Stefano Guidi, Chiara Dellacasa, Antonella Gozzini, Irene Donnini, Chiara Nozzoli, Sara Manetta, Semra Aydin, Luisa Giaccone, Moreno Festuccia, Lucia Brunello, Enrico Maffini, Benedetto Bruno, Ezio David, Alessandro Busca
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 10, Iss 1, Pp e2018001-e2018001 (2018)
Hepatic Veno-occlusive disease (VOD) is a potentially severe complication of hematopoietic stem cell transplantation (HSCT). Here we report two patients receiving an allogeneic HSCT who developed late onset VOD with atypical clinical features. The tw
Externí odkaz:
https://doaj.org/article/92fd73adce0e49529d89c7a07d19ba10
Autor:
Maher Hanoun, Lewin Eisele, Masako Suzuki, John M Greally, Andreas Hüttmann, Semra Aydin, René Scholtysik, Ludger Klein-Hitpass, Ulrich Dührsen, Jan Dürig
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e34347 (2012)
Disruption of circadian rhythm is believed to play a critical role in cancer development. Cryptochrome 1 (CRY1) is a core component of the mammalian circadian clock and we have previously shown its deregulated expression in a subgroup of patients wit
Externí odkaz:
https://doaj.org/article/90463603a82440d4a52cfa3953def144
Autor:
Ahmet UCAKTURK, Semra AYDIN
Publikováno v:
Journal of Global Strategic Management.